View in EDS

Siltuximab for chimeric antigen receptor T-cell therapy-related CRS and ICANS: a multicenter retrospective analysis.

Saved in:
Bibliographic Details
Title: Siltuximab for chimeric antigen receptor T-cell therapy-related CRS and ICANS: a multicenter retrospective analysis.
Authors: Bajwa A; The James Comprehensive Cancer Center, Division of Hematology, The Ohio State University, Columbus, OH., Zhao Q; The James Comprehensive Cancer Center, Division of Hematology, The Ohio State University, Columbus, OH., Geer M; Rogel Cancer Center, Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI., Lin C; Duke Cancer Center, Division of Hematology, Duke University, Durham, NC., Westholder J; Masonic Cancer Center, Division of Hematology and Oncology, University of Minnesota, Minneapolis, MN., Maakaron J; Masonic Cancer Center, Division of Hematology and Oncology, University of Minnesota, Minneapolis, MN., Ghosh M; Rogel Cancer Center, Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI., Frame D; Rogel Cancer Center, Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI., Galal A; Duke Cancer Center, Division of Hematology, Duke University, Durham, NC., Tossey J; The James Comprehensive Cancer Center, Division of Hematology, The Ohio State University, Columbus, OH., Ahmed N; University of Kansas Cancer Center, Division of Hematologic Malignancies and Cellular Therapeutics, Overland Park, KS., Bezerra E; The James Comprehensive Cancer Center, Division of Hematology, The Ohio State University, Columbus, OH., Denlinger N; The James Comprehensive Cancer Center, Division of Hematology, The Ohio State University, Columbus, OH., de Lima M; The James Comprehensive Cancer Center, Division of Hematology, The Ohio State University, Columbus, OH., Epperla N; The James Comprehensive Cancer Center, Division of Hematology, The Ohio State University, Columbus, OH., Caimi P; Taussig Cancer Institute, Division of Hematology and Medical Oncology, Cleveland Clinic Foundation, Cleveland, OH., Voorhees T; The James Comprehensive Cancer Center, Division of Hematology, The Ohio State University, Columbus, OH.
Source: Blood advances [Blood Adv] 2025 Jan 14; Vol. 9 (1), pp. 170-175.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39437770
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Siltuximab for chimeric antigen receptor T-cell therapy-related CRS and ICANS: a multicenter retrospective analysis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Bajwa+A%22">Bajwa A</searchLink>; The James Comprehensive Cancer Center, Division of Hematology, The Ohio State University, Columbus, OH.<br /><searchLink fieldCode="AU" term="%22Zhao+Q%22">Zhao Q</searchLink>; The James Comprehensive Cancer Center, Division of Hematology, The Ohio State University, Columbus, OH.<br /><searchLink fieldCode="AU" term="%22Geer+M%22">Geer M</searchLink>; Rogel Cancer Center, Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI.<br /><searchLink fieldCode="AU" term="%22Lin+C%22">Lin C</searchLink>; Duke Cancer Center, Division of Hematology, Duke University, Durham, NC.<br /><searchLink fieldCode="AU" term="%22Westholder+J%22">Westholder J</searchLink>; Masonic Cancer Center, Division of Hematology and Oncology, University of Minnesota, Minneapolis, MN.<br /><searchLink fieldCode="AU" term="%22Maakaron+J%22">Maakaron J</searchLink>; Masonic Cancer Center, Division of Hematology and Oncology, University of Minnesota, Minneapolis, MN.<br /><searchLink fieldCode="AU" term="%22Ghosh+M%22">Ghosh M</searchLink>; Rogel Cancer Center, Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI.<br /><searchLink fieldCode="AU" term="%22Frame+D%22">Frame D</searchLink>; Rogel Cancer Center, Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI.<br /><searchLink fieldCode="AU" term="%22Galal+A%22">Galal A</searchLink>; Duke Cancer Center, Division of Hematology, Duke University, Durham, NC.<br /><searchLink fieldCode="AU" term="%22Tossey+J%22">Tossey J</searchLink>; The James Comprehensive Cancer Center, Division of Hematology, The Ohio State University, Columbus, OH.<br /><searchLink fieldCode="AU" term="%22Ahmed+N%22">Ahmed N</searchLink>; University of Kansas Cancer Center, Division of Hematologic Malignancies and Cellular Therapeutics, Overland Park, KS.<br /><searchLink fieldCode="AU" term="%22Bezerra+E%22">Bezerra E</searchLink>; The James Comprehensive Cancer Center, Division of Hematology, The Ohio State University, Columbus, OH.<br /><searchLink fieldCode="AU" term="%22Denlinger+N%22">Denlinger N</searchLink>; The James Comprehensive Cancer Center, Division of Hematology, The Ohio State University, Columbus, OH.<br /><searchLink fieldCode="AU" term="%22de+Lima+M%22">de Lima M</searchLink>; The James Comprehensive Cancer Center, Division of Hematology, The Ohio State University, Columbus, OH.<br /><searchLink fieldCode="AU" term="%22Epperla+N%22">Epperla N</searchLink>; The James Comprehensive Cancer Center, Division of Hematology, The Ohio State University, Columbus, OH.<br /><searchLink fieldCode="AU" term="%22Caimi+P%22">Caimi P</searchLink>; Taussig Cancer Institute, Division of Hematology and Medical Oncology, Cleveland Clinic Foundation, Cleveland, OH.<br /><searchLink fieldCode="AU" term="%22Voorhees+T%22">Voorhees T</searchLink>; The James Comprehensive Cancer Center, Division of Hematology, The Ohio State University, Columbus, OH.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101698425%22">Blood advances</searchLink> [Blood Adv] 2025 Jan 14; Vol. 9 (1), pp. 170-175.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Hematology%22">American Society of Hematology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101698425 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-9537 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224739529%22">24739529 </searchLink><i>NLM ISO Abbreviation: </i>Blood Adv <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39437770
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1182/bloodadvances.2024013688
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 170
    Titles:
      – TitleFull: Siltuximab for chimeric antigen receptor T-cell therapy-related CRS and ICANS: a multicenter retrospective analysis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bajwa A
      – PersonEntity:
          Name:
            NameFull: Zhao Q
      – PersonEntity:
          Name:
            NameFull: Geer M
      – PersonEntity:
          Name:
            NameFull: Lin C
      – PersonEntity:
          Name:
            NameFull: Westholder J
      – PersonEntity:
          Name:
            NameFull: Maakaron J
      – PersonEntity:
          Name:
            NameFull: Ghosh M
      – PersonEntity:
          Name:
            NameFull: Frame D
      – PersonEntity:
          Name:
            NameFull: Galal A
      – PersonEntity:
          Name:
            NameFull: Tossey J
      – PersonEntity:
          Name:
            NameFull: Ahmed N
      – PersonEntity:
          Name:
            NameFull: Bezerra E
      – PersonEntity:
          Name:
            NameFull: Denlinger N
      – PersonEntity:
          Name:
            NameFull: de Lima M
      – PersonEntity:
          Name:
            NameFull: Epperla N
      – PersonEntity:
          Name:
            NameFull: Caimi P
      – PersonEntity:
          Name:
            NameFull: Voorhees T
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 14
              M: 01
              Text: 2025 Jan 14
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2473-9537
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Blood advances
              Type: main
ResultId 1